| Nestle India |
| Nestle India announced that the Board of Directors of the Company at its meeting held on 21 April 2026, has recommended a Final Dividend of Rs.5 per share (i.e.500%), subject to the approval of the shareholders. |
| Glaxosmi. Pharma |
| Glaxosmithkline Pharmaceuticals announced that Vinay Subramanian, Commercial Head – Oncology would be part of leadership team effective 20 April 2026 based out of Mumbai, and he would be part of senior Management Personnel of the Company effective the said date. Vinay brings with him over 24 years of experience in the Pharmaceuticals, Life Science. Healthcare Devices, and Medical Technology sectors. Prior to joining GSK. he served as the India Enabling leader - Enterprise & Neighboring Countries at Roche Products India Pvt ltd. where he was responsible for the immunotherapy portfolio and was part of their leadership team. |
| AGI Greenpac |
| AGI Greenpac will hold a meeting of the Board of Directors of the Company on 27 April 2026. |
| Kirl.Pneumatic |
| Kirloskar Pneumatic Company will hold a meeting of the Board of Directors of the Company on 27 April 2026. |
| NELCO |
| NELCO announced that the Board of Directors of the Company at its meeting held on 20 April 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders. |